A closer look

Medical transitioning requires walking a highly technical hematological tightrope. Transmasculine individuals undergoing gender-affirming hormone therapy must be monitored for secondary polycythemia. The heavy influx of testosterone commands the bone marrow to wildly overproduce red blood cells, literally turning the blood into a thick, sludgy consistency that drastically increases the risk of spontaneous strokes if not aggressively managed.